The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer
Affiliations: Korea Research Institute of Bioscience and Biotechnology, Daejeon 305‑333, Republic of Korea, Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea, Division of Molecular Modification and Cancer Biology, National Cancer Center, Tokyo 104‑0045, Japan
- Published online on: October 26, 2018 https://doi.org/10.3892/ijo.2018.4608
- Pages: 65-76
Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.